Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response
2006 · Nature Medicine · 2,102 citations
https://doi.org/10.1038/nm1358
J
John E.J. Rasko
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
432
Papers
20.4K
Citations
71
h-index
198
i10-index
John E.J. Rasko is an academic researcher from The University of Sydney. The author has contributed to research in topics: RNA modifications and cancer & RNA Research and Splicing & CAR-T cell therapy research. The author has an h-index of 71, co-authored 368 publications.
ORCID: 0000-0003-2975-807XPapers by this author
worksHemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
2017 · New England Journal of Medicine · 738 citations
https://doi.org/10.1056/nejmoa1708538
IRFinder: assessing the impact of intron retention on mammalian gene expression
2017 · Genome biology · 331 citations
https://doi.org/10.1186/s13059-017-1184-4
Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A
2021 · New England Journal of Medicine · 234 citations
https://doi.org/10.1056/nejmoa2104205
Genetic alterations of m6A regulators predict poorer survival in acute myeloid leukemia
2017 · Journal of Hematology & Oncology · 205 citations
https://doi.org/10.1186/s13045-017-0410-6
Surveying brain tumor heterogeneity by single-cell RNA-sequencing of multi-sector biopsies
2020 · National Science Review · 177 citations
https://doi.org/10.1093/nsr/nwaa099
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat